BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 25539241)

  • 1. Evaluation of MRI-TRUS fusion versus cognitive registration accuracy for MRI-targeted, TRUS-guided prostate biopsy.
    Cool DW; Zhang X; Romagnoli C; Izawa JI; Romano WM; Fenster A
    AJR Am J Roentgenol; 2015 Jan; 204(1):83-91. PubMed ID: 25539241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion.
    Fiard G; Hohn N; Descotes JL; Rambeaud JJ; Troccaz J; Long JA
    Urology; 2013 Jun; 81(6):1372-8. PubMed ID: 23540865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Real-time MRI/US fusion-guided biopsy improves detection rates of prostate cancer in pre-biopsied patients].
    Maxeiner A; Fischer T; Stephan C; Cash H; Slowinski T; Kilic E; Durmus T
    Aktuelle Urol; 2014 May; 45(3):197-203. PubMed ID: 24902069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Real-time MRI/US fusion-guided biopsy in biopsy-naïve and pre-biopsied patients with suspicion for prostate cancer].
    Maxeiner A; Stephan C; Fischer T; Durmus T; Kilic E; Asbach P; Haas M; Günzel K; Neymeyer J; Miller K; Cash H
    Aktuelle Urol; 2015 Jan; 46(1):34-8. PubMed ID: 25519051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies.
    Arsov C; Rabenalt R; Blondin D; Quentin M; Hiester A; Godehardt E; Gabbert HE; Becker N; Antoch G; Albers P; Schimmöller L
    Eur Urol; 2015 Oct; 68(4):713-20. PubMed ID: 26116294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
    Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
    World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elastic Versus Rigid Image Registration in Magnetic Resonance Imaging-transrectal Ultrasound Fusion Prostate Biopsy: A Systematic Review and Meta-analysis.
    Venderink W; de Rooij M; Sedelaar JPM; Huisman HJ; Fütterer JJ
    Eur Urol Focus; 2018 Mar; 4(2):219-227. PubMed ID: 28753777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI-directed cognitive fusion-guided biopsy of the anterior prostate tumors.
    Murphy IG; NiMhurchu E; Gibney RG; McMahon CJ
    Diagn Interv Radiol; 2017; 23(2):87-93. PubMed ID: 28074780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion-guided biopsy increase the detection of anteriorly located prostate cancers.
    Volkin D; Turkbey B; Hoang AN; Rais-Bahrami S; Yerram N; Walton-Diaz A; Nix JW; Wood BJ; Choyke PL; Pinto PA
    BJU Int; 2014 Dec; 114(6b):E43-E49. PubMed ID: 24712649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incremental diagnostic value of targeted biopsy using mpMRI-TRUS fusion versus 14-fragments prostatic biopsy: a prospective controlled study.
    Mariotti GC; Falsarella PM; Garcia RG; Queiroz MRG; Lemos GC; Baroni RH
    Eur Radiol; 2018 Jan; 28(1):11-16. PubMed ID: 28687911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy.
    Baco E; Rud E; Eri LM; Moen G; Vlatkovic L; Svindland A; Eggesbø HB; Ukimura O
    Eur Urol; 2016 Jan; 69(1):149-56. PubMed ID: 25862143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy.
    Martin PR; Cool DW; Fenster A; Ward AD
    Med Phys; 2018 Mar; 45(3):1018-1028. PubMed ID: 29363762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
    Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
    Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting Prostate Cancer.
    Brock M; von Bodman C; Palisaar J; Becker W; Martin-Seidel P; Noldus J
    Dtsch Arztebl Int; 2015 Sep; 112(37):605-11. PubMed ID: 26396046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of image registration accuracy in three-dimensional transrectal ultrasound guided prostate biopsy.
    Karnik VV; Fenster A; Bax J; Cool DW; Gardi L; Gyacskov I; Romagnoli C; Ward AD
    Med Phys; 2010 Feb; 37(2):802-13. PubMed ID: 20229890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional value of magnetic resonance-targeted biopsies to standard transrectal ultrasound-guided biopsies for detection of clinically significant prostate cancer.
    von Below C; Wassberg C; Norberg M; Tolf A; Kullberg J; Ladjevardi S; Häggman M; Bill Axelson A; Ahlström H
    Scand J Urol; 2017 Apr; 51(2):107-113. PubMed ID: 28635568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.